AR Nissenson, SD Nimer, DL Wolcott - Annals of internal medicine, 1991 - Am Coll Physicians Anemia (hematocrit < 25%) predictably accompanies chronic renal failure and is present in over
90% of patients on chronic dialysis. Relative erythropoietin deficiency is the proximate
cause. Recombinant human erythropoietin recently became available for research and ... Cited by 53 - Related articles - All 4 versions
AR Nissenson - Seminars in nephrology, 1989 - ncbi.nlm.nih.gov The clinical manifestations of uremia are only incompletely reversed by chronic
hemodialysis. Signs and symptoms can include abnormalities in electrophysiologic indices, clinical
mental status, and neuropsychological test performance, as well as decreases in exercise ... Cited by 48 - Related articles
SM Korbet, EF Vonesh, CA Firanek - … diseases: the official journal of the …, 1991 - ncbi.nlm.nih.gov Eight stable patients, from our institution, on continuous ambulatory peritoneal dialysis
(CAPD) were entered into a multicenter, randomized, double-blind, placebo-controlled study
with erythropoietin (EP]. To assess the effect of hematocrit on peritoneal solute transport, ... Cited by 16 - Related articles - All 4 versions
- ►pdiconnect.com [PDF] LA Frenken, DG Struijk, PJ Coppens, RG … - Peritoneal Dialysis …, 1992 - pdiconnect.com .Objective: To determine the efficacy and safety of intraperitoneal administration of recombinant
human erythropoietin (rHuEPO) in continuous ambulatory peritoneal dialysis (CAPD) patients
compared to subcutaneous rHuEPO. .Design: Prospective analysis of an open, ... Cited by 16 - Related articles - BL Direct - All 5 versions
HH Neumayer, J Brockmöller, E Fritschka, I … - Contributions to …, 1989 - ncbi.nlm.nih.gov 1: Contrib Nephrol. 1989;76:131-41; discussion 141-2. Pharmacokinetics of recombinant
human erythropoietin after SC administration and in long-term IV treatment in patients
on maintenance hemodialysis. Neumayer HH, Brockmöller ... Cited by 24 - Related articles - All 2 versions
- ►pdiconnect.com [PDF] JM Bargman, A Breborowicz, H Rodela, K … - Peritoneal Dialysis …, 1988 - pdiconnect.com Toronto Western Hospital, Toronto, Ontario, Canada Previous protocols of administration of recombinant
human erythropoietin to patients with end-stage renal disease have been by the iv route. Because
this method would be impractical for the continuous ambulatory peritoneal dialysis ... Cited by 24 - Related articles - All 4 versions
B Varet, N Casadevall, C Lacombe, P … - Seminars in hematology, 1990 - ncbi.nlm.nih.gov Erythropoietin is a glycoprotein hormone of primarily renal origin that promotes the proliferation
and differentiation of erythrocyte precursors. Technological advances have resulted in the production
of recombinant hormone suitable for therapeutic use and have permitted significant ... Cited by 25 - Related articles
[CITATION] Epogen study group: a double-blind, placebo-controlled study of recombinant …
